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We read with interest the recent report on gingival overgrowth
due to amlodipine.1 We would like to make a few remarks
while sharing our experience with this condition in an elderly
lady. While on amlodipine, she developed insidious gingival
overgrowth (Fig. 1) without any signs of inﬂammation. This
was completely reversible which may not always be the case.2
'Overgrowth' is the preferred term rather than gingival
hypertrophy.3 Unattended, it may even lead to tooth loss.
Treating and maintaining patients on amlodipine in peri-
odontal practice involves considerable extra treatment and
cost.2 Overgrowth may not always be a class effect, because
overgrowth has disappeared in a person who switched over to
isradipine from nifedipine.4 Half of the patients experience
long-term recurrence.2Fig. 1 – Figure showing gingival overgrowth due to
amlodipine.The pathogenesis is related to its mechanism of action.
Amlodipine reduces Ca2+ cell inﬂux, leading to a reduction in
the uptake of folic acid, limiting the production of active
collagenase.5 Collagen is normally degraded by collagenases.
Because of reduction in degradation, collagen accumulates in
connective tissue matrix of gingiva.
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